30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
Suppose a contractor or subcontractor is involved in a major renovation or expansion project such as...
Read More >
On January 28, 2020, the U.S. Federal Trade Commission (FTC) announced the annual changes to the thr...
Read More >
The New York City Department of City Planning (DCP) provided greater detail on its proposal to rezon...
Read More >
On September 11, 2019, the California Assembly passed a bill codifying last year’s Supreme Court of...
Read More >
The recent Employment Tribunal decision in Dewhurst and others v. Revisecatch & City Sprint has held...
Read More >
The Daily Journal of Commerce recently reported that increased demand for mass-timber material, such...
Read More >